Filing Details
- Accession Number:
- 0001883850-22-000056
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-08-11 16:09:31
- Reporting Period:
- 2022-08-09
- Accepted Time:
- 2022-08-11 16:09:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 872589 | Regeneron Pharmaceuticals Inc. | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1189014 | A Christine Poon | 777 Old Saw Mill River Road Tarrytown NY 10591 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-08-09 | 15,000 | $177.82 | 16,872 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-08-09 | 6,814 | $620.47 | 10,058 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-08-09 | 8,186 | $621.27 | 1,872 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2022-08-09 | 15,000 | $0.00 | 15,000 | $177.82 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2023-01-02 | No | 4 | M | Direct |
Footnotes
- Represents volume-weighted average price of sales of 6,814 shares of Company stock on August 9, 2022 at prices ranging from $620.20 to $620.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 9, 2022 at each separate price.
- Represents volume-weighted average price of sales of 8,186 shares of Company stock on August 9, 2022 at prices ranging from $621.01 to $621.33. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 9, 2022 at each separate price.
- The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.
Billionaire Hedge Funds
